IBDEI31K ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50991,1,3,0)
 ;;=3^Bursopathies, oth site, oth, spec
 ;;^UTILITY(U,$J,358.3,50991,1,4,0)
 ;;=4^M71.88
 ;;^UTILITY(U,$J,358.3,50991,2)
 ;;=^5133868
 ;;^UTILITY(U,$J,358.3,50992,0)
 ;;=M71.89^^222^2466^78
 ;;^UTILITY(U,$J,358.3,50992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50992,1,3,0)
 ;;=3^Bursopathies, multpl sites, oth, spec
 ;;^UTILITY(U,$J,358.3,50992,1,4,0)
 ;;=4^M71.89
 ;;^UTILITY(U,$J,358.3,50992,2)
 ;;=^5013231
 ;;^UTILITY(U,$J,358.3,50993,0)
 ;;=R76.0^^222^2466^212
 ;;^UTILITY(U,$J,358.3,50993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50993,1,3,0)
 ;;=3^Raised antibody titer
 ;;^UTILITY(U,$J,358.3,50993,1,4,0)
 ;;=4^R76.0
 ;;^UTILITY(U,$J,358.3,50993,2)
 ;;=^5019569
 ;;^UTILITY(U,$J,358.3,50994,0)
 ;;=R76.9^^222^2466^2
 ;;^UTILITY(U,$J,358.3,50994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50994,1,3,0)
 ;;=3^Abnl immunological fndgs in serum, unspec
 ;;^UTILITY(U,$J,358.3,50994,1,4,0)
 ;;=4^R76.9
 ;;^UTILITY(U,$J,358.3,50994,2)
 ;;=^5019573
 ;;^UTILITY(U,$J,358.3,50995,0)
 ;;=M31.7^^222^2466^190
 ;;^UTILITY(U,$J,358.3,50995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50995,1,3,0)
 ;;=3^Microscopic polyangiitis
 ;;^UTILITY(U,$J,358.3,50995,1,4,0)
 ;;=4^M31.7
 ;;^UTILITY(U,$J,358.3,50995,2)
 ;;=^5011749
 ;;^UTILITY(U,$J,358.3,50996,0)
 ;;=M31.4^^222^2466^58
 ;;^UTILITY(U,$J,358.3,50996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50996,1,3,0)
 ;;=3^Aortic arch syndrome [Takayasu]
 ;;^UTILITY(U,$J,358.3,50996,1,4,0)
 ;;=4^M31.4
 ;;^UTILITY(U,$J,358.3,50996,2)
 ;;=^5011746
 ;;^UTILITY(U,$J,358.3,50997,0)
 ;;=I77.6^^222^2466^59
 ;;^UTILITY(U,$J,358.3,50997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50997,1,3,0)
 ;;=3^Arteritis, unspec
 ;;^UTILITY(U,$J,358.3,50997,1,4,0)
 ;;=4^I77.6
 ;;^UTILITY(U,$J,358.3,50997,2)
 ;;=^5007813
 ;;^UTILITY(U,$J,358.3,50998,0)
 ;;=M26.62^^222^2466^60
 ;;^UTILITY(U,$J,358.3,50998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50998,1,3,0)
 ;;=3^Arthralgia of temporomandibular joint
 ;;^UTILITY(U,$J,358.3,50998,1,4,0)
 ;;=4^M26.62
 ;;^UTILITY(U,$J,358.3,50998,2)
 ;;=^270034
 ;;^UTILITY(U,$J,358.3,50999,0)
 ;;=M12.9^^222^2466^61
 ;;^UTILITY(U,$J,358.3,50999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50999,1,3,0)
 ;;=3^Arthropathy, unspec
 ;;^UTILITY(U,$J,358.3,50999,1,4,0)
 ;;=4^M12.9
 ;;^UTILITY(U,$J,358.3,50999,2)
 ;;=^5010666
 ;;^UTILITY(U,$J,358.3,51000,0)
 ;;=M35.2^^222^2466^62
 ;;^UTILITY(U,$J,358.3,51000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51000,1,3,0)
 ;;=3^Behcet's disease
 ;;^UTILITY(U,$J,358.3,51000,1,4,0)
 ;;=4^M35.2
 ;;^UTILITY(U,$J,358.3,51000,2)
 ;;=^263705
 ;;^UTILITY(U,$J,358.3,51001,0)
 ;;=I82.91^^222^2466^94
 ;;^UTILITY(U,$J,358.3,51001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51001,1,3,0)
 ;;=3^Chron embolism & thrombosis of unspec vein
 ;;^UTILITY(U,$J,358.3,51001,1,4,0)
 ;;=4^I82.91
 ;;^UTILITY(U,$J,358.3,51001,2)
 ;;=^5007941
 ;;^UTILITY(U,$J,358.3,51002,0)
 ;;=M1A.30X1^^222^2466^151
 ;;^UTILITY(U,$J,358.3,51002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51002,1,3,0)
 ;;=3^Gout, chron d/t renal imprmnt, unsp site, w/ tophus (tophi)
 ;;^UTILITY(U,$J,358.3,51002,1,4,0)
 ;;=4^M1A.30X1
 ;;^UTILITY(U,$J,358.3,51002,2)
 ;;=^5010960
 ;;^UTILITY(U,$J,358.3,51003,0)
 ;;=M1A.9XX1^^222^2466^155
 ;;^UTILITY(U,$J,358.3,51003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51003,1,3,0)
 ;;=3^Gout, chron, unspec, w/ tophus (tophi)
 ;;^UTILITY(U,$J,358.3,51003,1,4,0)
 ;;=4^M1A.9XX1
 ;;^UTILITY(U,$J,358.3,51003,2)
 ;;=^5133773
 ;;^UTILITY(U,$J,358.3,51004,0)
 ;;=Z79.52^^222^2466^188
 ;;^UTILITY(U,$J,358.3,51004,1,0)
 ;;=^358.31IA^4^2
